Concepedia

Jewel Johl

JJ

Statistics

Publications

4

Citations

98

H-Index

4

Active since

1986

Affiliations

University of Pittsburgh(Current)

Jewel Johl is an author at University of Pittsburgh specializing in medicine, pharmacology, and cancer pharmacology.

Publications per year

1986–2014

4

Publications

4

Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and-resistant P388 cells

David Streeter, Jewel Johl, G. R. Gordon et al. · Cancer Chemotherapy and Pharmacology · 1986 · 41 citations

Medicine, Pharmacokinetics, Pharmacology +14

The proteasome inhibitor PS-341 (bortezomib) in platinum (plat)-treated extensive-stage small cell lung cancer (E-SCLC): A SWOG (0327) phase II trial

Jewel Johl, Kari Chansky, Primo N. Lara et al. · Journal of Clinical Oncology · 2005 · 22 citations

Medicine, Oncology, Pharmacology +15

Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients

Norah A. Terrault, K. Rajender Reddy, Fred Poordad et al. · American Journal of Transplantation · 2014 · 21 citations · Full text

Pharmacy, Infectious Diseases, Infectious Disease Pharmacotherapy +14

Frequent expression of the tumor necrosis factor receptor–associated factor 1 in latent membrane protein 1–Positive posttransplant lymphoproliferative disease and HIV-associated lymphomas

Lode J. Swinnen, Joanne R. Flavell, Margaret V. Ragni et al. · Human Pathology · 2001 · 14 citations

Medicine, Immunology, Pathology +10

1–4 of 4